pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 25·1 min read
save

Comments on OMB Research Rule Disappear from Government Site, Raising Transparency Concerns

Aug 25, 2026·read at STAT ↗RegulatoryNegative

A federal website that hosted public comments on a proposed Office of Management and Budget research rule was found to have removed several submissions, according to a report.

The rule under consideration would allow greater political input into how federal science funds are allocated, prompting scrutiny from stakeholders who fear politicization of research.

One commenter, a mother whose child was diagnosed with cystic fibrosis, shared how new therapies have improved outcomes, and expressed worry that the rule could affect future funding for such advances.

The agency also deleted posts that referenced the diagnosis of the director Russell Vought’s daughter, adding to concerns about selective removal of content.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Comments on OMB research rule mysteriously removed from federal website”

read at STAT ↗
636 words · retrieved Aug 25
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
(elexacaftor + ivacaftor + tezacaftor) + ivacaftor3
topics
Cystic Fibrosis3Vaccine

related stories

  • Aug 25With mRNA back in the spotlight, tRNA shows potential to treat genetic diseaseFierce Biotech
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 2d agoFoghorn cuts 40% of workforceBioSpace
  • Sep 23ReCode CEO Suliman leaves cystic fibrosis mission in mentee’s handsBioSpace
  • Sep 15Sionna lays off 46% of workforce in strategic shift after cystic fibrosis trial failFierce Biotech